查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
胰島素的全球市場(2022年～2028年):各產品，各用途，各類型，各流通管道，各地區的市場規模調查與預測
市場調查報告書
商品編碼
1105743

胰島素的全球市場(2022年～2028年):各產品，各用途，各類型，各流通管道，各地區的市場規模調查與預測

Global Insulin Market Size study, by Product by Application, by Type, by Distribution Channel and Regional Forecasts 2022-2028
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

全球胰島素的市場規模，2021年約203億5,000萬美金，2022年～2028年的預測期間內預計以超過1.5％的健全成長率擴大。

牽引市場的主要原因，有糖尿病罹患率的上升和製劑開發等。可是，第二型糖尿病的治療藥物GLP-1 RA等的處方增加，市場成長有停滯的可能性。

本報告提供全球胰島素市場調查，市場概要，市場的推動因素與阻礙因素的分析，市場機會，COVID-19影響，各市場區隔的市場分析，競爭情形，主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 全球胰島素市場:定義和範圍

第3章 全球胰島素:市場動態

  • 胰島素市場:影響分析(2020年～2028年)

第4章 全球胰島素市場:產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論
  • 主要的投資機會
  • 主要的成功策略

第5章 風險評估:COVID-19影響

    • COVID-19對產業的整體影響的評估
    • COVID-19前及COVID-19後的市場情境

第6章 全球胰島素市場:各產品

  • 市場概述
  • 成果:潛力分析
  • 市場規模的估計與預測(2018年～2028年)
  • 子區隔分析
    • 速效型胰島素
    • 持久性功效型胰島素
    • 並用胰島素
    • 生物相似藥
    • 其他

第7章 全球胰島素市場:各類型

  • 市場概述
  • 成果:潛力分析
  • 市場規模的估計與預測(2018年～2028年)
  • 子區隔分析
    • 第一型糖尿病
    • 第二型糖尿病

第8章 全球胰島素市場:各用途

  • 市場概述
  • 成果:潛力分析
  • 市場規模的估計與預測(2018年～2028年)
  • 子區隔分析
    • 胰島素注射液
    • 胰島素類似物

第9章 全球胰島素市場:各流通管道

  • 市場概述
  • 成果:潛力分析
  • 市場規模的估計與預測(2018年～2028年)
  • 子區隔分析
    • 醫院
    • 零售藥局
    • 其他

第10章 全球胰島素市場:地區分析

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 全球其他地區

第11章 競爭情形

  • 主要市場策略
  • 企業簡介
    • Novo Nordisk A/S
    • Eli Lilly and Company
    • Sanofi
    • Biocon Ltd
    • Wockhardt
    • Boehringer Ingelheim International GmbH
    • Julphar
    • United Laboratories International Holdings Limited
    • Tonghua Dongbao Pharmaceutical Co. Ltd.
    • Pfizer

第12章 調查流程

Global Insulin Market is valued approximately USD 20.35 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2022-2028. Insulin is a hormone produced by the pancreas that regulates the amount of glucose in the bloodstream at any given time. The insulin market is expanding as a result of factors such as rising diabetes prevalence and formulation developments. However, rising prescriptions for medications like GLP-1 RAs to treat type 2 diabetes may halt market growth. It's an oligopolistic market dominated by Novo Nordisk A/S, Sanofi, and Eli Lilly and Company. Diabetes is one of the world's fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades. According to the World Health Organization, diabetes will afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Another important component driving space increase is formulation advancements. Fiasp (Novo Nordisk) is a formulation of insulin aspart in a combination with niacinamide (Vitamin-B3), which helps boost the drug's early absorption. Afrezza (Mannkind) is the market's sole inhaled version, which eliminates the need for needles and syringes. In addition, Oramed Pharmaceuticals' oral insulin capsule is in phase 3 clinical studies. The BLA is planned to be submitted by the end of Q4 2023. The successful launch of this product may provide patients with an alternative option. However, the high cost of insulin stifles market growth throughout the forecast period of 2022-2028.

The key regions considered for the Global Insulin Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue in 2021, owing to the dominance of branded products and the region's increasing disease prevalence. According to the CDC, there will be roughly 37.3 million diabetics in the United States in 2020, including 28.7 million diagnosed and 8.5 million undiagnosed cases. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for biosimilar development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

Novo Nordisk A/S

Eli Lilly and Company

Sanofi

Biocon Ltd

Wockhardt

Boehringer Ingelheim International GmbH

Julphar

United Laboratories International Holdings Limited

Tonghua Dongbao Pharmaceutical Co. Ltd.

Pfizer

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Rapid-Acting Insulin

Long-Acting Insulin

Combination Insulin

Biosimilar

Others

By Type:

Type 1 Diabetes Mellitus

Type 2 Diabetes Mellitus

By Application:

Human Insulin

Insulin Analog

By Distribution Channel:

Hospitals

Retail Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Insulin Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Insulin Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Insulin Market, by Product, 2020-2028 (USD Billion)
    • 1.2.3. Insulin Market, by Type, 2020-2028 (USD Billion)
    • 1.2.4. Insulin Market, by Application, 2020-2028 (USD Billion)
    • 1.2.5. Insulin Market, by Distribution Channel, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Insulin Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Insulin Market Dynamics

  • 3.1. Insulin Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of diabetes
      • 3.1.1.2. Growing gGeriatric pPopulation
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cCost of Insulin
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Advancements in fFormulation

Chapter 4. Global Insulin Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Insulin Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Insulin Market by Product, Performance - Potential Analysis
  • 6.3. Global Insulin Market Estimates & Forecasts by Product 2018-2028 (USD Billion)
  • 6.4. Insulin Market, Sub Segment Analysis
    • 6.4.1. Rapid-Acting Insulin
    • 6.4.2. Long-Acting Insulin
    • 6.4.3. Combination Insulin
    • 6.4.4. Biosimilar
    • 6.4.5. Others

Chapter 7. Global Insulin Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Insulin Market by Type, Performance - Potential Analysis
  • 7.3. Global Insulin Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
  • 7.4. Insulin Market, Sub Segment Analysis
    • 7.4.1. Type 1 Diabetes Mellitus
    • 7.4.2. Type 2 Diabetes Mellitus

Chapter 8. Global Insulin Market, by Application

  • 8.1. Market Snapshot
  • 8.2. Global Insulin Market by Application, Performance - Potential Analysis
  • 8.3. Global Insulin Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
  • 8.4. Insulin Market, Sub Segment Analysis
    • 8.4.1. Human Insulin
    • 8.4.2. Insulin Analog

Chapter 9. Global Insulin Market, by Distribution Channel

  • 9.1. Market Snapshot
  • 9.2. Global Insulin Market by Distribution Channel, Performance - Potential Analysis
  • 9.3. Global Insulin Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Billion)
  • 9.4. Insulin Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Others

Chapter 10. Global Insulin Market, Regional Analysis

  • 10.1. Insulin Market, Regional Market Snapshot
  • 10.2. North America Insulin Market
    • 10.2.1. U.S. Insulin Market
      • 10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
      • 10.2.1.2. Type breakdown estimates & forecasts, 2018-2028
      • 10.2.1.3. Application breakdown estimates & forecasts, 2018-2028
      • 10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2018-2028
    • 10.2.2. Canada Insulin Market
  • 10.3. Europe Insulin Market Snapshot
    • 10.3.1. U.K. Insulin Market
    • 10.3.2. Germany Insulin Market
    • 10.3.3. France Insulin Market
    • 10.3.4. Spain Insulin Market
    • 10.3.5. Italy Insulin Market
    • 10.3.6. Rest of Europe Insulin Market
  • 10.4. Asia-Pacific Insulin Market Snapshot
    • 10.4.1. China Insulin Market
    • 10.4.2. India Insulin Market
    • 10.4.3. Japan Insulin Market
    • 10.4.4. Australia Insulin Market
    • 10.4.5. South Korea Insulin Market
    • 10.4.6. Rest of Asia Pacific Insulin Market
  • 10.5. Latin America Insulin Market Snapshot
    • 10.5.1. Brazil Insulin Market
    • 10.5.2. Mexico Insulin Market
  • 10.6. Rest of The World Insulin Market

Chapter 11. Competitive Intelligence

  • 11.1. Top Market Strategies
  • 11.2. Company Profiles
    • 11.2.1. Novo Nordisk A/S
      • 11.2.1.1. Key Information
      • 11.2.1.2. Overview
      • 11.2.1.3. Financial (Subject to Data Availability)
      • 11.2.1.4. Product Summary
      • 11.2.1.5. Recent Developments
    • 11.2.2. Eli Lilly and Company
    • 11.2.3. Sanofi
    • 11.2.4. Biocon Ltd
    • 11.2.5. Wockhardt
    • 11.2.6. Boehringer Ingelheim International GmbH
    • 11.2.7. Julphar
    • 11.2.8. United Laboratories International Holdings Limited
    • 11.2.9. Tonghua Dongbao Pharmaceutical Co. Ltd.
    • 11.2.10. Pfizer

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Insulin Market, report scope
  • TABLE 2. Global Insulin Market estimates & forecasts by Region 2018-2028 (USD Billion)
  • TABLE 3. Global Insulin Market estimates & forecasts by Product 2018-2028 (USD Billion)
  • TABLE 4. Global Insulin Market estimates & forecasts by Type 2018-2028 (USD Billion)
  • TABLE 5. Global Insulin Market estimates & forecasts by Application 2018-2028 (USD Billion)
  • TABLE 6. Global Insulin Market estimates & forecasts by Distribution Channel 2018-2028 (USD Billion)
  • TABLE 7. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 8. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 9. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 10. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 11. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 12. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 13. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 14. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 15. Global Insulin Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 16. Global Insulin Market by region, estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 17. U.S. Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 18. U.S. Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 19. U.S. Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 20. Canada Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 21. Canada Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 22. Canada Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 23. UK Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 24. UK Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 25. UK Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 26. Germany Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 27. Germany Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 28. Germany Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 29. RoE Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 30. RoE Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 31. RoE Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 32. China Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 33. China Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 34. China Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 35. India Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 36. India Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 37. India Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 38. Japan Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 39. Japan Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 40. Japan Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 41. RoAPAC Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 42. RoAPAC Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 43. RoAPAC Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 44. Brazil Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 45. Brazil Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 46. Brazil Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 47. Mexico Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 48. Mexico Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 49. Mexico Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 50. RoLA Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 51. RoLA Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 52. RoLA Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 53. Row Insulin Market estimates & forecasts, 2018-2028 (USD Billion)
  • TABLE 54. Row Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 55. Row Insulin Market estimates & forecasts by segment 2018-2028 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Insulin Market
  • TABLE 57. List of primary sources, used in the study of global Insulin Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Insulin Market, research methodology
  • FIG 2. Global Insulin Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Insulin Market, key trends 2021
  • FIG 5. Global Insulin Market, growth prospects 2022-2028
  • FIG 6. Global Insulin Market, porters 5 force model
  • FIG 7. Global Insulin Market, pest analysis
  • FIG 8. Global Insulin Market, value chain analysis
  • FIG 9. Global Insulin Market by segment, 2018 & 2028 (USD Billion)
  • FIG 10. Global Insulin Market by segment, 2018 & 2028 (USD Billion)
  • FIG 11. Global Insulin Market by segment, 2018 & 2028 (USD Billion)
  • FIG 12. Global Insulin Market by segment, 2018 & 2028 (USD Billion)
  • FIG 13. Global Insulin Market by segment, 2018 & 2028 (USD Billion)
  • FIG 14. Global Insulin Market, regional snapshot 2018 & 2028
  • FIG 15. North America Insulin Market 2018 & 2028 (USD Billion)
  • FIG 16. Europe Insulin Market 2018 & 2028 (USD Billion)
  • FIG 17. Asia pacific Insulin Market 2018 & 2028 (USD Billion)
  • FIG 18. Latin America Insulin Market 2018 & 2028 (USD Billion)
  • FIG 19. Global Insulin Market, company Market share analysis (2021)